⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 24, 2024Frontiers in OncologyOpen Access

A three miRNAs panel in paraffin tissue serves as tool for predicting prognosis of renal cell carcinoma

Wenkang Chen Wuping Wang Zhengping Zhao Zhenyu Wen Yingqi Li Zhenjian Ge Yongqing Lai Liangchao Ni

View Full Paper

Ask AI

Bookmark

Share

Abstract

Renal cell carcinoma (RCC) stands as the most prevalent form of urogenital cancer. However, there is currently no universally accepted method for predicting the prognosis of RCC. MiRNA holds great potential as a prognostic biomarker for RCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e6de61b6db643587659b43 https://doi.org/10.3389/fonc.2024.1391844

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell CarcinomaPrognostic Study · 2021 · 6 citations
2miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma2024 · 5 citations
3Urine and Blood-Derived MicroRNAs in Patients with Kidney Cancer: A Review of Clinical Utility and Recent DevelopmentsLiterature Review · 2026
4Liquid Biopsy in Clear Cell Renal Cell Carcinoma: Diagnostic Potential of Urinary miRNAsOriginal Research · 2026 · 3 citations
5A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR studyClinical Trial · 2025